Doctors Endorsing Products on X May Not Disclose Company Ties

  • 📰 Medscape
  • ⏱ Reading Time:
  • 40 sec. here
  • 15 min. at publisher
  • 📊 Quality Score:
  • News: 64%
  • Publisher: 55%

Cancer Nouvelles

Malignant Neoplasia,Carcinoma,Malignant Neoplasm

Almost one third of physicians who endorsed drugs or devices on X don't disclose that they receive payments from the company, a new analysis found.

Lead author Aaron Mitchell, MD, MPH, a medical oncologist at Memorial Sloan Kettering Cancer Center in New York City, toldthat he and his colleagues undertook the study in part to see whether physicians were adhering to professional and industry guidelines regarding marketing communications.

While most did disclose that the posts were sponsored — by adding the word"sponsored" or using #sponsored — nine physicians did not. Among the physician specialties promoting a product, urologists and oncologists dominated. Almost one third were urologists, and 57% were oncologists — six medical oncologists, six radiation oncologists, and four gynecologic oncologists. Of the remaining three physicians, two were internists and one was a pulmonary and critical care medicine specialist.

In general, Mitchell said, industry guidelines suggest that manufacturer-paid speakers or consultants should have well-regarded expertise in the area they are being asked to weigh in on, but most physician endorsers in the study were not key opinion leaders or experts.

 

Merci pour votre commentaire. Votre commentaire sera publié après examen.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 386. in BE

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Crypto investment products see $2 billion of inflows in May amid 'turnaround' in Ethereum sentiment: CoinSharesEthereum-based products saw their second consecutive week of net inflows totaling $33.5 million following spot ETF approvals on May 23.
La source: TheBlock__ - 🏆 464. / 53 Lire la suite »